{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:20:19Z","timestamp":1777026019657,"version":"3.51.4"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31230-8","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T10:57:05Z","timestamp":1765450625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In silico-driven identification of potent CDK9 inhibitors through bioisosteric replacement and multi-stage virtual screening"],"prefix":"10.1038","volume":"16","author":[{"given":"Juliana","family":"Amorim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Altamirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Silva","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda Abida","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carpio","family":"Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"16","key":"31230_CR1","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray, F., Laversanne, M., Weiderpass, E. & Soerjomataram, I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127(16), 3029\u20133030 (2021).","journal-title":"Cancer"},{"issue":"2","key":"31230_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3322\/caac.21834","volume":"4","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN). J. Nat. Cancer Center. 4(2), 128\u2013134. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"J. Nat. Cancer Center."},{"key":"31230_CR3","doi-asserted-by":"publisher","unstructured":"Lin, H. Y. & Park, J. Y. Epidemiology of Cancer. in Anesthesia for Oncological Surgery (2024). https:\/\/doi.org\/10.1007\/978-3-031-50977-3_2.","DOI":"10.1007\/978-3-031-50977-3_2"},{"key":"31230_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-26890-9","volume":"13","author":"O Gaidai","year":"2023","unstructured":"Gaidai, O., Yan, P. & Xing, Y. Future world cancer death rate prediction. Sci. Rep. 13, 1\u20139 (2023).","journal-title":"Sci. Rep."},{"key":"31230_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00659-2","author":"S Anandasabapathy","year":"2024","unstructured":"Anandasabapathy, S., Asirwa, C., Grover, S. & Mungo, C. Cancer burden in low-income and middle-income countries. Nat. Rev. Cancer https:\/\/doi.org\/10.1038\/s41568-023-00659-2 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"31230_CR6","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","volume":"21","author":"JS Brown","year":"2023","unstructured":"Brown, J. S. et al. Updating the definition of cancer. Mol. Cancer Res. 21, 1142\u20131147 (2023).","journal-title":"Mol. Cancer Res."},{"key":"31230_CR7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev-biochem-052410-090317","volume":"81","author":"JA Endicott","year":"2012","unstructured":"Endicott, J. A., Noble, M. E. M. & Johnson, L. N. The structural basis for control of eukaryotic protein kinases. Annu. Rev. Biochem. 81, 587\u2013613 (2012).","journal-title":"Annu. Rev. Biochem."},{"issue":"6","key":"31230_CR8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/gb4184","volume":"15","author":"M Malumbres","year":"2014","unstructured":"Malumbres, M. Cyclin-dependent kinases. Genome Biol. 15(6), 122 (2014).","journal-title":"Genome Biol."},{"key":"31230_CR9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","volume":"9","author":"M Malumbres","year":"2009","unstructured":"Malumbres, M. & Barbacid, M. Cell cycle, CDKs and cancer: A changing paradigm. Nat. Rev. Cancer 9, 153\u2013166 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"31230_CR10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/ncb1109-1275","volume":"11","author":"M Malumbres","year":"2009","unstructured":"Malumbres, M. et al. Cyclin-dependent kinases: A family portrait. Nat. Cell Biol. 11, 1275\u20131276 (2009).","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"31230_CR11","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.3390\/cancers13092181","volume":"13","author":"R Mandal","year":"2021","unstructured":"Mandal, R., Becker, S. & Strebhardt, K. Targeting CDK9 for anti-cancer therapeutics. Cancers 13(9), 2181 (2021).","journal-title":"Cancers"},{"key":"31230_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2021.678559","volume":"11","author":"AT Anshabo","year":"2021","unstructured":"Anshabo, A. T., Milne, R., Wang, S. & Albrecht, H. CDK9: A comprehensive review of its biology, and its role as a potential target for anti-cancer agents. Front. Oncol. 11, 1\u201324 (2021).","journal-title":"Front. Oncol."},{"key":"31230_CR13","first-page":"2078","volume":"12","author":"NF Marshall","year":"1992","unstructured":"Marshall, N. F. & Price, D. H. Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12, 2078\u20132090 (1992).","journal-title":"Mol. Cell. Biol."},{"key":"31230_CR14","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1073\/pnas.91.9.3834","volume":"91","author":"X Gra\u00f1a","year":"1994","unstructured":"Gra\u00f1a, X. et al. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl. Acad. Sci. USA. 91, 3834\u20133838 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"31230_CR15","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/emboj.2008.121","volume":"27","author":"S Baumli","year":"2008","unstructured":"Baumli, S. et al. The structure of P-TEFb (CDK9\/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. EMBO J. 27, 1907\u20131918 (2008).","journal-title":"EMBO J."},{"key":"31230_CR16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nchembio.2538","volume":"14","author":"CM Olson","year":"2018","unstructured":"Olson, C. M. et al. Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. Nat. Chem. Biol. 14, 163\u2013170 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"31230_CR17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ejmech.2018.09.025","volume":"158","author":"B Wang","year":"2018","unstructured":"Wang, B. et al. Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor. Eur. J. Med. Chem. 158, 896\u2013916 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"31230_CR18","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1158\/1078-0432.CCR-19-1853","volume":"26","author":"J Cidado","year":"2020","unstructured":"Cidado, J. et al. AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematologic cancer cells. Clin. Cancer Res. 26, 922\u2013934 (2020).","journal-title":"Clin. Cancer Res."},{"key":"31230_CR19","doi-asserted-by":"publisher","unstructured":"Luecking, U. T. et al. Abstract 984: Identification of potent and highly selective PTEFb inhibitor BAY 1251152 for the treatment of cancer: from p.o. to i.v. application via scaffold hops. In: Proc. of the American Association for Cancer Research Annual Meeting https:\/\/aacrjournals.org\/cancerres\/article\/77\/13_Supplement\/984\/622158\/Abstract-984-Identification-of-potent-and-highly (2017) https:\/\/doi.org\/10.1158\/1538-7445.AM2017-984.","DOI":"10.1158\/1538-7445.AM2017-984"},{"key":"31230_CR20","doi-asserted-by":"publisher","unstructured":"Scholz, A. et al. Abstract DDT02\u201302: BAY 1143572: A first-in-class, highly selective, potent and orally available inhibitor of PTEFb\/CDK9 currently in Phase I, inhibits MYC and shows convincing anti-tumor activity in multiple xenograft models by the induction of apoptosis. In: Proc. of the 106th Annual Meeting of the American Association for Cancer Research (2015) https:\/\/doi.org\/10.1158\/1538-7445.AM2015-DDT02-02.","DOI":"10.1158\/1538-7445.AM2015-DDT02-02"},{"key":"31230_CR21","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1182\/blood-2018-99-117257","volume":"132","author":"M Byrne","year":"2018","unstructured":"Byrne, M. et al. Phase I study of the PTEFb inhibitor BAY 1251152 in patients with acute myelogenous leukemia. Blood 132, 4055\u20134055 (2018).","journal-title":"Blood"},{"key":"31230_CR22","doi-asserted-by":"crossref","unstructured":"Rule, S. et al. A phase 1, open-label, multicenter, non-randomized study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of AZD4573, a potent and selective CDK9 inhibitor, in subjects with relapsed or refractory hematological mali. J. Clin. Oncol. 36, (2018).","DOI":"10.1200\/JCO.2018.36.15_suppl.TPS7588"},{"key":"31230_CR23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/cancers7010179","volume":"7","author":"M Peyressatre","year":"2015","unstructured":"Peyressatre, M., Pr\u00e9vel, C., Pellerano, M. & Morris, M. C. Targeting cyclin-dependent kinases in human cancers: From small molecules to peptide inhibitors. Cancers 7, 179\u2013237 (2015).","journal-title":"Cancers"},{"key":"31230_CR24","doi-asserted-by":"crossref","first-page":"8667","DOI":"10.1021\/acs.jmedchem.6b00150","volume":"59","author":"YA Sonawane","year":"2016","unstructured":"Sonawane, Y. A. et al. Cyclin dependent kinase 9 inhibitors for cancer therapy. J. Med. Chem. 59, 8667\u20138684 (2016).","journal-title":"J. Med. Chem."},{"key":"31230_CR25","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.2174\/138161212800672750","volume":"18","author":"V Krystof","year":"2012","unstructured":"Krystof, V., Baumli, S. & Furst, R. Perspective of cyclin-dependent kinase 9 (CDK9) as a drug target. Curr. Pharm. Des. 18, 2883\u20132890 (2012).","journal-title":"Curr. Pharm. Des."},{"key":"31230_CR26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1039\/D2MD00040G","volume":"13","author":"Z Huang","year":"2022","unstructured":"Huang, Z., Wang, T., Wang, C. & Fan, Y. CDK9 inhibitors in cancer research. RSC Med. Chem. 13, 688\u2013710 (2022).","journal-title":"RSC Med. Chem."},{"key":"31230_CR27","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.107055","volume":"161","author":"A Ghosh","year":"2023","unstructured":"Ghosh, A., Mukherjee, S., Jha, P. C. & Manhas, A. Identifying natural product inhibitors against CDK9 enzyme via combined multicomplex-based pharmacophore modeling, interaction studies and molecular dynamics simulations. Comput. Biol. Med. 161, 107055 (2023).","journal-title":"Comput. Biol. Med."},{"key":"31230_CR28","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1039\/D3CP05582E","volume":"26","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Potent inhibitors targeting cyclin-dependent kinase 9 discovered via virtual high-throughput screening and absolute binding free energy calculations. Phys. Chem. Chem. Phys. 26, 5377\u20135386 (2024).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"31230_CR29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/nar\/gkl999","volume":"35","author":"T Liu","year":"2007","unstructured":"Liu, T., Lin, Y., Wen, X., Jorissen, R. N. & Gilson, M. K. BindingDB: A web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res. 35, 198\u2013201 (2007).","journal-title":"Nucleic Acids Res."},{"key":"31230_CR30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2174\/1573409915666190704093400","volume":"16","author":"J Shan","year":"2020","unstructured":"Shan, J. & Ji, C. MolOpt: A web server for drug design using bioisosteric transformation. Curr. Comput. Aided. Drug Des. 16, 460\u2013466 (2020).","journal-title":"Curr. Comput. Aided. Drug Des."},{"key":"31230_CR31","unstructured":"Landrum, G. RDKit: Open-Source Cheminformatics. https:\/\/www.rdkit.org (2006)."},{"key":"31230_CR32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"CR Harris","year":"2020","unstructured":"Harris, C. R. et al. Array programming with NumPy. Nature 585, 357\u2013362 (2020).","journal-title":"Nature"},{"key":"31230_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-1","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open babel: An open chemical toolbox. J. Cheminform. 3, 1\u201314 (2011).","journal-title":"J. Cheminform."},{"key":"31230_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules23123094","volume":"23","author":"A Kutlushina","year":"2018","unstructured":"Kutlushina, A., Khakimova, A., Madzhidov, T. & Polishchuk, P. Ligand-based pharmacophore modeling using novel 3D pharmacophore signatures. Molecules 23, 1\u201314 (2018).","journal-title":"Molecules"},{"key":"31230_CR35","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger, M. M., Carchia, M., Irwin, J. J. & Shoichet, B. K. Directory of useful decoys, enhanced (DUD-E): Better ligands and decoys for better benchmarking. J. Med. Chem. 55, 6582\u20136594 (2012).","journal-title":"J. Med. Chem."},{"key":"31230_CR36","doi-asserted-by":"crossref","first-page":"W442","DOI":"10.1093\/nar\/gkw287","volume":"44","author":"J Sunseri","year":"2016","unstructured":"Sunseri, J. & Koes, D. R. Pharmit: Interactive exploration of chemical space. Nucleic Acids Res. 44, W442\u2013W448 (2016).","journal-title":"Nucleic Acids Res."},{"key":"31230_CR37","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1021\/acs.jcim.6b00283","volume":"56","author":"C Empereur-Mot","year":"2016","unstructured":"Empereur-Mot, C., Zagury, J. F. & Montes, M. Screening explorer-an interactive tool for the analysis of screening results. J. Chem. Inf. Model. 56, 2281\u20132286 (2016).","journal-title":"J. Chem. Inf. Model."},{"key":"31230_CR38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","volume":"64","author":"CA Lipinski","year":"2012","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 64, 4\u201317 (2012).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"31230_CR39","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","volume":"57","author":"A Cherkasov","year":"2014","unstructured":"Cherkasov, A. et al. QSAR modeling: Where have you been? Where are you going to?. J. Med. Chem. 57, 4977\u20135010 (2014).","journal-title":"J. Med. Chem."},{"key":"31230_CR40","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/jcc.23361","volume":"34","author":"P Gramatica","year":"2013","unstructured":"Gramatica, P., Chirico, N., Papa, E., Cassani, S. & Kovarich, S. QSARINS: A new software for the development, analysis, and validation of QSAR MLR models. J. Comput. Chem. 34, 2121\u20132132 (2013).","journal-title":"J. Comput. Chem."},{"issue":"7","key":"31230_CR41","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/jcc.21707","volume":"32","author":"CW Yap","year":"2011","unstructured":"Yap, C. W. PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints. J. Comput. Chem. 32(7), 1466\u20131474 (2011).","journal-title":"J. Comput. Chem."},{"key":"31230_CR42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10822-011-9440-2","volume":"25","author":"I Sushko","year":"2011","unstructured":"Sushko, I. et al. Online chemical modeling environment (OCHEM): Web platform for data storage, model development and publishing of chemical information. J. Comput. Aided. Mol. Des. 25, 533\u2013554 (2011).","journal-title":"J. Comput. Aided. Mol. Des."},{"key":"31230_CR43","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/jcc.26551","volume":"42","author":"N Chirico","year":"2021","unstructured":"Chirico, N. et al. QSARINS-Chem standalone version: A new platform-independent software to profile chemicals for physico-chemical properties, fate, and toxicity. J. Comput. Chem. 42, 1452\u20131460 (2021).","journal-title":"J. Comput. Chem."},{"key":"31230_CR44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander, T., Freyss, J., Von Korff, M. & Rufener, C. DataWarrior: An open-source program for chemistry aware data visualization and analysis. J. Chem. Inf. Model. 55, 460\u2013473 (2015).","journal-title":"J. Chem. Inf. Model."},{"key":"31230_CR45","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.bmcl.2016.06.013","volume":"26","author":"N Zhang","year":"2016","unstructured":"Zhang, N. & Zhao, H. Enriching screening libraries with bioactive fragment space. Bioorganic Med. Chem. Lett. 26, 3594\u20133597 (2016).","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"31230_CR46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1021\/ci800298z","volume":"49","author":"O Korb","year":"2009","unstructured":"Korb, O., St\u00fctzle, T. & Exner, T. E. Empirical scoring functions for advanced protein-ligand docking with PLANTS. J. Chem. Inf. Model. 49, 84\u201396 (2009).","journal-title":"J. Chem. Inf. Model."},{"key":"31230_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1003571","volume":"10","author":"S Ruiz-Carmona","year":"2014","unstructured":"Ruiz-Carmona, S. et al. rDock: A fast, versatile and open source program for docking ligands to proteins and nucleic acids. PLoS Comput. Biol. 10, 1\u20137 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"31230_CR48","first-page":"1","volume":"2013","author":"U Schulze-Gahmen","year":"2013","unstructured":"Schulze-Gahmen, U. et al. The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat. Elife 2013, 1\u201314 (2013).","journal-title":"Elife"},{"issue":"2","key":"31230_CR49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MH Olsson","year":"2011","unstructured":"Olsson, M. H., S\u00f8ndergaard, C. R., Rostkowski, M. & Jensen, J. H. PROPKA3: Consistent treatment of internal and surface residues in empirical p K a predictions. J. Chem. Theor. Comput. 7(2), 525\u2013537 (2011).","journal-title":"J. Chem. Theor. Comput."},{"key":"31230_CR50","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel, D. et al. GROMACS: Fast, flexible, and free. J. Comput. Chem. 26, 1701\u20131718 (2005).","journal-title":"J. Comput. Chem."},{"key":"31230_CR51","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","volume":"8","author":"RB Best","year":"2012","unstructured":"Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03c6, \u03c8 and side-chain \u03c71 and \u03c72 dihedral angles. J. Chem. Theory Comput. 8, 3257\u20133273 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"31230_CR52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/andp.19213690304","volume":"369","author":"PP Ewald","year":"1921","unstructured":"Ewald, P. P. Die Berechnung optischer und elektrostatischer Gitterpotentiale. Ann. Phys. 369, 253\u2013287 (1921).","journal-title":"Ann. Phys."},{"key":"31230_CR53","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463\u20131472 (1997).","journal-title":"J. Comput. Chem."},{"key":"31230_CR54","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","volume":"33","author":"PA Kollman","year":"2000","unstructured":"Kollman, P. A. et al. Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Acc. Chem. Res. 33, 889\u2013897 (2000).","journal-title":"Acc. Chem. Res."},{"key":"31230_CR55","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M. S., Vald\u00e9s-Tresanco, M. E., Valiente, P. A. & Moreno, E. Gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS. J. Chem. Theory Comput. 17, 6281\u20136291 (2021).","journal-title":"J. Chem. Theory Comput."},{"issue":"21","key":"31230_CR56","doi-asserted-by":"crossref","first-page":"14450","DOI":"10.1039\/C7CP07623A","volume":"20","author":"H Sun","year":"2018","unstructured":"Sun, H. et al. Assessing the performance of MM\/PBSA and MM\/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches. Phys. Chem. Chem. Phys. 20(21), 14450\u201314460 (2018).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"31230_CR57","first-page":"449","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. J. Comput. Chem. 10, 449\u2013461 (2015).","journal-title":"J. Comput. Chem."},{"key":"31230_CR58","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/jcc.24839","volume":"38","author":"N Ch\u00e9ron","year":"2017","unstructured":"Ch\u00e9ron, N. & Shakhnovich, E. I. Effect of sampling on BACE-1 ligands binding free energy predictions via MM-PBSA calculations. J. Comput. Chem. 38, 1941\u20131951 (2017).","journal-title":"J. Comput. Chem."},{"key":"31230_CR59","first-page":"1","volume":"12","author":"F Neese","year":"2022","unstructured":"Neese, F. Software update: The ORCA program system\u2014Version 50. Rev. Comput. Mol. Sci. 12, 1\u201315 (2022).","journal-title":"Rev. Comput. Mol. Sci."},{"key":"31230_CR60","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2014A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"31230_CR61","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1039\/C8SC04175J","volume":"10","author":"R Winter","year":"2019","unstructured":"Winter, R., Montanari, F., No\u00e9, F. & Clevert, D. A. Learning continuous and data-driven molecular descriptors by translating equivalent chemical representations. Chem. Sci. 10, 1692\u20131701 (2019).","journal-title":"Chem. Sci."},{"key":"31230_CR62","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1021\/ci800038f","volume":"48","author":"H Hong","year":"2008","unstructured":"Hong, H. et al. Mold2, molecular descriptors from 2D structures for chemoinformatics and toxicoinformatics. J. Chem. Inf. Model. 48, 1337\u20131344 (2008).","journal-title":"J. Chem. Inf. Model."},{"key":"31230_CR63","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/1062936X.2011.569900","volume":"22","author":"K Roy","year":"2011","unstructured":"Roy, K. & Das, R. N. On some novel extended topochemical atom (ETA) parameters for effective encoding of chemical information and modelling of fundamental physicochemical properties. SAR QSAR Environ. Res. 22, 451\u2013472 (2011).","journal-title":"SAR QSAR Environ. Res."},{"key":"31230_CR64","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/acs.jcim.6b00088","volume":"56","author":"P Gramatica","year":"2016","unstructured":"Gramatica, P. & Sangion, A. A historical excursus on the statistical validation parameters for QSAR models: A clarification concerning metrics and terminology. J. Chem. Inf. Model. 56, 1127\u20131131 (2016).","journal-title":"J. Chem. Inf. Model."},{"key":"31230_CR65","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/minf.201200075","volume":"31","author":"P Gramatica","year":"2012","unstructured":"Gramatica, P. et al. QSAR modeling is not \u2018Push a button and find a correlation\u2019: A case study of toxicity of (Benzo-)triazoles on Algae. Mol. Inform. 31, 817\u2013835 (2012).","journal-title":"Mol. Inform."},{"key":"31230_CR66","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1158\/1078-0432.CCR-15-0313","volume":"21","author":"MEM Dolman","year":"2015","unstructured":"Dolman, M. E. M. et al. Cyclin-dependent kinase inhibitor AT7519 as a potential drug for MYCN-dependent neuroblastoma. Clin. Cancer Res. 21, 5100\u20135109 (2015).","journal-title":"Clin. Cancer Res."},{"key":"31230_CR67","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1039\/D2CB00201A","volume":"4","author":"I Hope","year":"2022","unstructured":"Hope, I., Endicott, J. A. & Watt, J. E. Emerging approaches to CDK inhibitor development, a structural perspective. RSC Chem. Biol. 4, 146\u2013164 (2022).","journal-title":"RSC Chem. Biol."},{"key":"31230_CR68","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/jm301475f","volume":"56","author":"H Shao","year":"2013","unstructured":"Shao, H. et al. Substituted 4-(thiazol-5-yl)-2-(phenylamino)pyrimidines are highly active CDK9 inhibitors: Synthesis, X-ray crystal structures, structure-activity relationship, and anticancer activities. J. Med. Chem. 56, 640\u2013659 (2013).","journal-title":"J. Med. Chem."},{"key":"31230_CR69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1747519820932091","volume":"45","author":"M Miar","year":"2021","unstructured":"Miar, M., Shiroudi, A., Pourshamsian, K., Oliaey, A. R. & Hatamjafari, F. Theoretical investigations on the HOMO\u2013LUMO gap and global reactivity descriptor studies, natural bond orbital, and nucleus-independent chemical shifts analyses of 3-phenylbenzo[d]thiazole-2(3H)-imine and its para-substituted derivatives: Solvent and subs. J. Chem. Res. 45, 147\u2013158 (2021).","journal-title":"J. Chem. Res."},{"key":"31230_CR70","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1021\/acs.jctc.7b01252","volume":"14","author":"D Hait","year":"2018","unstructured":"Hait, D. & Head-Gordon, M. How accurate is density functional theory at predicting dipole moments? An assessment using a new database of 200 benchmark values. J. Chem. Theory Comput. 14, 1969\u20131981 (2018).","journal-title":"J. Chem. Theory Comput."},{"key":"31230_CR71","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1021\/jp502475e","volume":"118","author":"AL Hickey","year":"2014","unstructured":"Hickey, A. L. & Rowley, C. N. Benchmarking quantum chemical methods for the calculation of molecular dipole moments and polarizabilities. J. Phys. Chem. A 118, 3678\u20133687 (2014).","journal-title":"J. Phys. Chem. A"},{"key":"31230_CR72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-26890-9","volume":"13","author":"SA Ejaz","year":"2023","unstructured":"Ejaz, S. A., Aziz, M., Zafar, Z., Akhtar, N. & Ogaly, H. A. Revisiting the inhibitory potential of protein kinase inhibitors against NEK7 protein via comprehensive computational investigations. Sci. Rep. 13, 1\u201318 (2023).","journal-title":"Sci. Rep."},{"key":"31230_CR73","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0031-8914(34)90011-2","volume":"1","author":"T Koopmans","year":"1934","unstructured":"Koopmans, T. \u00dcber die Zuordnung von Wellenfunktionen und Eigenwerten zu den Einzelnen Elektronen Eines Ato. Physica 1, 104\u2013113 (1934).","journal-title":"Physica"},{"key":"31230_CR74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molstruc.2015.06.041","volume":"1099","author":"G Elmaci","year":"2015","unstructured":"Elmaci, G., Aktan, E., Sefero\u0287lu, N., H\u00f6kelek, T. & Sefero\u0287lu, Z. Synthesis, molecular structure and computational study of (Z)-2-((E)-4-nitrobenzylidene)hydrazone)-1,2-diphenylethan-1-one. J. Mol. Struct. 1099, 83\u201391 (2015).","journal-title":"J. Mol. Struct."},{"key":"31230_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-50600-8","volume":"14","author":"DF Tegegn","year":"2024","unstructured":"Tegegn, D. F., Belachew, H. Z. & Salau, A. O. DFT\/TDDFT calculations of geometry optimization, electronic structure and spectral properties of clevudine and telbivudine for treatment of chronic hepatitis B. Sci. Rep. 14, 1\u201319 (2024).","journal-title":"Sci. Rep."},{"key":"31230_CR76","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138595","volume":"1313","author":"T Benlatreche","year":"2024","unstructured":"Benlatreche, T. et al. Synthesis, crystal structure, in vitro anticholinesterase activity, molecular docking and DFT investigation of three 1,10-phenanthroline-tin(IV) complexes. J. Mol. Struct. 1313, 138595 (2024).","journal-title":"J. Mol. Struct."},{"key":"31230_CR77","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.2174\/0115701808306787240709073814","volume":"21","author":"A Guendouze","year":"2024","unstructured":"Guendouze, A., Mokrani, E. H., Benslama, O. & Lekmine, S. Exploring the potential of avenanthramides and their analogues as \u03b1-glucosidase inhibitors for type 2 diabetes treatment utilizing virtual screening, molecular dynamics, and drug-likeness predictions. Lett. Drug Des. Discov. 21, 3858\u20133871 (2024).","journal-title":"Lett. Drug Des. Discov."},{"key":"31230_CR78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fchem.2024.1473398","volume":"12","author":"AA Alsfouk","year":"2024","unstructured":"Alsfouk, A. A., Faris, A., Cacciatore, I. & Alnajjar, R. Development of novel CDK9 and CYP3A4 inhibitors for cancer therapy through field and computational approaches. Front. Chem. 12, 1\u201317 (2024).","journal-title":"Front. Chem."},{"key":"31230_CR79","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2023.108003","volume":"108","author":"I Habib","year":"2024","unstructured":"Habib, I. et al. Integrated computational approaches for designing potent pyrimidine-based CDK9 inhibitors: 3D-QSAR, docking, and molecular dynamics simulations. Comput. Biol. Chem. 108, 108003 (2024).","journal-title":"Comput. Biol. Chem."},{"issue":"11","key":"31230_CR80","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3389\/fphar.2020.01230","volume":"13","author":"M Cassandri","year":"2020","unstructured":"Cassandri, M. et al. CDK9 as a valuable target in cancer: From natural compounds inhibitors to current treatment in pediatric soft tissue sarcomas. Front. Pharmacol. 13(11), 1230 (2020).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31230-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31230-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31230-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T18:04:09Z","timestamp":1767463449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31230-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31230"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31230-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that they are not aware of any financial interests or personal relationships that could have influenced the outcomes of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}